Awarded contractOpenSuppliesPoland
BISPECYFICZNE PRZECIWCIAŁO naśladujące aktywny czynnik VIII wraz z sukcesywnymi dostawami do Ośrodków Leczenia Hemofilii i Pokrewnych Skaz Krwotocznych oraz domów pacjentów; znak postępowania: ZZP.ZP.411.100.2026
1 supplier awarded•1 lot awarded•€28.78M awarded
Buyer: Narodowe Centrum Krwi / Warszawa, Poland
Published Oct 22, 2026Awarded Oct 07, 2026
Medicinal products for the blood and blood-forming organs
Awarded value
€28.78M
Estimated value
€28.78M
Awarded at 100% of estimated value
Award date
Oct 07, 2026
Winners
1
Lots awarded
1
Winners
Roche Polska Sp. z o.o.
1 lotWarszawa, POL
€28.8M This contract
32 award notices•54 awarded lots•€58.1M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0001 | Roche Polska Sp. z o.o. | €28.8M | Medicinal products for the blood and blood-forming organs (33621000) |